Breast Cancer Blood Flow and Metabolism on Dual-Acquisition 18F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response
Conclusion: Of the two biologic hallmarks of cancer evaluated in this study, a reduction in tumor glucose metabolism was more accurate than a reduction in tumor BF for predicting pCR in the different subtypes of breast cancer.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Humbert, O., Lasserre, M., Bertaut, A., Fumoleau, P., Coutant, C., Brunotte, F., Cochet, A. Tags: Clinical Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Eating Disorders & Weight Management | HER2 | Herceptin | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nuclear Medicine | Obesity | Study | Women